Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Molecular Response (PDX business unit)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of translational oncology drug discovery services. The unit provides PDX models as well as 8000 viable human tumors for model development services.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • San Diego, CA 92121
  • United States

Molecular Response (PDX business unit) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Molecular Response (PDX business unit)‘s full profile, request access.

Request full access to PitchBook

Molecular Response (PDX business unit) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Molecular Response (PDX business unit)‘s full profile, request access.

Request full access to PitchBook